AHA today Oct. 24 a Special Bulletin with updates from Baxter on its efforts to increase access to and supply of IV solutions in response to the effects of Hurricane Helene on its manufacturing facility in North Carolina. Baxter anticipates restarting the highest-throughput IV solutions manufacturing line at the impacted plant within the next week. In addition, the Food and Drug Administration authorized temporary importation for a variety of products from two additional Baxter plants in Thailand and Singapore, bringing the total number of facilities authorized to import products to seven. See AHA’s Special Bulletin for more updates.

Chairperson's File
Public
At every hour of every day, people across the U.S. count on their local hospital. For many people, emergencies happen without warning — a heart attack,…
Headline
The Administration for Strategic Preparedness and Response announced Nov. 3 that it will partner with the Bureau of Industry and Security and the Assistant…
Headline
The Department of Health and Human Services announced Oct. 22 that it is seeking subject matter experts to apply to serve on the National Biodefense Science…
Headline
The Department of Health and Human Services Sept. 18 announced the launch of a new personal protective equipment forecast to identify, consolidate and publish…
Perspective
Public
Twenty-five years ago, our nation experienced one of the darkest days in its history. The terrorist attacks of Sept. 11, 2001, took thousands of innocent lives…
Headline
The Centers for Medicare & Medicaid Services’ six-month moratorium on the enrollment of new durable medical equipment, prosthetics, orthotics and supply…